Clinical neurology and epidemiology of the major neurodegenerative diseases
MG Erkkinen, MO Kim… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …
older adults. Most clinicians who care for the elderly are not trained to diagnose these …
Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis
Objective To describe the comparative efficacy of drug and non-drug interventions for
reducing symptoms of depression in people with dementia who experience depression as a …
reducing symptoms of depression in people with dementia who experience depression as a …
Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy
J Olazarán, B Reisberg, L Clare, I Cruz… - Dementia and geriatric …, 2010 - karger.com
Abstract Introduction: Nonpharmacological therapies (NPTs) can improve the quality of life
(QoL) of people with Alzheimer's disease (AD) and their carers. The objective of this study …
(QoL) of people with Alzheimer's disease (AD) and their carers. The objective of this study …
EFNS guidelines for the diagnosis and management of Alzheimer's disease
J Hort, JT O'Brien, G Gainotti, T Pirttila… - European Journal of …, 2010 - Wiley Online Library
Background and objectives: In 2008 a task force was set up to develop a revision of the
European Federation of the Neurological Societies (EFNS) guideline for the diagnosis and …
European Federation of the Neurological Societies (EFNS) guideline for the diagnosis and …
Nonpharmacologic management of behavioral symptoms in dementia
Behavioral symptoms such as repetitive speech, wandering, and sleep disturbances are a
core clinical feature of Alzheimer disease and related dementias. If untreated, these …
core clinical feature of Alzheimer disease and related dementias. If untreated, these …
[HTML][HTML] Social prescription interventions addressing social isolation and loneliness in older adults: Meta-review integrating on-the-ground resources
C Paquet, J Whitehead, R Shah, AM Adams… - Journal of Medical …, 2023 - jmir.org
Background Social prescription programs represent a viable solution to linking primary care
patients to nonmedical community resources for improving patient well-being. However …
patients to nonmedical community resources for improving patient well-being. However …
Case management approaches to home support for people with dementia
S Reilly, C Miranda‐Castillo, R Malouf… - Cochrane Database …, 2015 - cochranelibrary.com
Background Over 35 million people are estimated to be living with dementia in the world and
the societal costs are very high. Case management is a widely used and strongly promoted …
the societal costs are very high. Case management is a widely used and strongly promoted …
Social health and dementia: a European consensus on the operationalization of the concept and directions for research and practice
Background: Because the pattern of illnesses changes in an aging population and many
people manage to live well with chronic diseases, a group of health care professionals …
people manage to live well with chronic diseases, a group of health care professionals …
The costs of dementia in Europe: an updated review and meta-analysis
Abstract Background and Objective The prevalence of dementia is increasing, while new
opportunities for diagnosing, treating and possibly preventing Alzheimer's disease and other …
opportunities for diagnosing, treating and possibly preventing Alzheimer's disease and other …
[HTML][HTML] A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial
RH Reindollar, MM Regan, PJ Neumann, BS Levine… - Fertility and sterility, 2010 - Elsevier
OBJECTIVE: To determine the value of gonadotropin/intrauterine insemination (FSH/IUI)
therapy for infertile women aged 21–39 years. DESIGN: Randomized controlled trial …
therapy for infertile women aged 21–39 years. DESIGN: Randomized controlled trial …